1989
DOI: 10.1056/nejm198910193211606
|View full text |Cite
|
Sign up to set email alerts
|

Liver Transplantation

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
61
0
3

Year Published

1990
1990
2007
2007

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 280 publications
(64 citation statements)
references
References 79 publications
0
61
0
3
Order By: Relevance
“…Its success is the result of progressive improvement of surgical techniques and immunosuppressive regimens for the prevention of transplant rejection [1,2]. Among pediatric patients, over 90% of all liver transplants are prompted by the existence of cholestatic disease (Table 1) or congenital metabolic deficits; other less common causes are metabolic liver disease, cystic fibrosis, and certain types of liver tumors (in most cases, hepatoblastoma and hepatocellular carcinoma) [3].…”
Section: Introductionmentioning
confidence: 99%
“…Its success is the result of progressive improvement of surgical techniques and immunosuppressive regimens for the prevention of transplant rejection [1,2]. Among pediatric patients, over 90% of all liver transplants are prompted by the existence of cholestatic disease (Table 1) or congenital metabolic deficits; other less common causes are metabolic liver disease, cystic fibrosis, and certain types of liver tumors (in most cases, hepatoblastoma and hepatocellular carcinoma) [3].…”
Section: Introductionmentioning
confidence: 99%
“…1,2 This change has been the result of improvements in referral liver transplant centers. Between April 1990 and immunosuppressive regimens, surgical techniques, recipient June 1994, 772 adults underwent an initial single-organ preparation, organ preservation, anesthesia techniques, timliver transplantion.…”
mentioning
confidence: 99%
“…Because of its dramatic effects on decreasing morbidity and increasing survival rates in human transplants (2,3), there has been much interest in deciphering CsA's molecular mechanism of immunosuppression. Evidence has accumulated on the one hand that T-cell CyP is a primary target for CsA (1,4) and on the other hand that the key biological step in immunosuppression is the selective blockade of transcriptional activation of T-cell cytokine genes for production of such molecules as interleukin 2, interleukin 3, and granulocyte-macrophage colonystimulating factor (5,6) by the inhibition of specific transcriptional activators such as nuclear factor of activated T cells (NF-AT) (7).…”
mentioning
confidence: 99%